Bladder cancer is a type of cancer that affects the urinary bladder. It is the sixth most common type of cancer in the United States and the fourth most common type of cancer in Europe. Symptoms of bladder cancer include blood in the urine, pain during urination, and frequent urination. Treatment options for bladder cancer include surgery, chemotherapy, radiation therapy, and immunotherapy. The oncology market for bladder cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new treatments to improve outcomes for patients, such as targeted therapies and immunotherapies. Additionally, research is being conducted to better understand the biology of bladder cancer and to develop new diagnostic tests. Companies in the bladder cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
